SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Prospector who wrote (2020)6/28/1998 9:06:00 PM
From: R>G>  Read Replies (1) | Respond to of 5402
 
Most Important Messages 0-2000 My Opinion Only
Latest Press release Message 4914356

Quartely Report (SEC form 10QSB) Message 4559439

Sanguine & Dr. Drees (CEO & President)
Message 4809638
Message 4830476
Message 4747631
Message 4831405
Message 4834342

Message 4839394
Message 4844175
Message 4845010
Message 4847265
Message 4873798

Message 4917415
Message 4955605
Message 4967939
Message 4979399
Message 4989379

Message 5036087
Message 5040793

Battelle
Message 4919150

Patent's and Patent Pending Granted
Message 4967447
Message 4968704

Competition
Message 4716401
Message 4750291
Message 4832639
Message 4842880
Message 4843334

Message 4846038
Message 4846476
Message 4846650
Message 4849143
Message 4899919

Message 4909963
Message 4949541
Message 4952340

Milestone's-Time-lines
Message 5019767

Part Two Tomorrow (General Information on blood, blood substitute's and Perfluorocarbons).

Do Not Forget The Information Thread. It is good.

Suggestions Welcomed!!



To: Prospector who wrote (2020)6/28/1998 9:57:00 PM
From: drdan  Respond to of 5402
 
Northfield's product is nearly finished with testing and will be first to market in this industry.... I don't know how well it will do long-term(especially compared to pfc-based products, assuming that some are approved), because it is based on human blood, but it will have no competition until other products are approved....